65,437 trials
Diabetes Mellitus, Non-Insulin-Dependent · High Risk for Cardiovascular Event
Primary: Subjects Included in the Composite Endpoint of CV Death, MI or Ischemic Stroke — 756; 803 Participants — p=0.172
HIV-1 Infection
Primary: Percentage of Participants Achieving HIV-1 Ribonucleic Acid (RNA) <50 Copies/mL of Plasma at Week 48 — 100.0 Percentage of Participants
Pneumococcal Infections
Primary: Percentage of Participants With Local Reactions Within 10 Days After Vaccination 1 — 7.3; 3.6; 3.6; 3.2 percentage of participants
Visual Acuity
Primary: Overall Comfort Score — 59.30; 58.54 Units on a Scale
Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders
Primary: Time to Adjudication Committee (AC)-Determined Neuromyelitis Optica Spectrum Disorder (NMOSD) Attack During RCP — NA; NA Days — p=<0.0001
Induction of Labor Affected Fetus / Newborn
Primary: Time From Beginning of Induction to Delivery — 13.8; 14.3 hours
Chronic Pain · Diabetic Neuropathies · Diabetes Mellitus
Primary: Change in Average Pain Intensity. — -2.24; -2.28; -2.56; -2.79 units on a scale — p=0.0621
EGFR Exon 19 Deletion Mutation · EGFR NP_005219.2:p.L858R · Lung Non-Squamous Non-Small Cell Carcinoma
Primary: Progression Free Survival (PFS) — 13.5; 17.9 months — p=0.39
HIV Infections
Primary: Proportion of Women With Plasma HIV-1 RNA Viral Load Less Than 200 Copies/mL at Delivery — .84; .94 Proportion — p=0.001
Circumference Reduction
Primary: Circumference Change in the Thighs at the 12-week Follow-up Compared to Baseline Measurements — -2.8 centimeter
BACTERIAL VAGINOSIS · Signs and Symptoms to be Evaluated and Recorded Include · Vaginal Discharge Color, Odor, and Consistency
Primary: Number of Participants With Both a Clinical and a Bacteriological Cure (Nugent Score <4), Evaluated at Visit 2 Test-of-cure (Study Day 22-30). — 36; 34; 9 Participants
Pulmonary Arterial Hypertension
Primary: Number of Participants Reporting at Least One Treatment-Emergent Adverse Event (TEAE) — 18 Participants
Tonsillectomy
Primary: Pain Assessment Using a Visual Analog Scale (VAS) — 5.4 units on a scale
Poor Quality Sleep · Fatigue
Primary: Sleep Quality — 7.9; 6.5 score on a scale — p=0.76
Autism Spectrum Disorder · ASD · Autism
Primary: Change in Social Communication as Measured by the Vineland Adaptive Behavior Scales, Third Edition (VABS-3) — 3.13; 1.98 score on a scale — p=0.83